In this upbeat interview, CEO Jerry Randall of Venture Life takes me through today’s better than anticipated results and ‘in line’ guidance - with FY’22 EBITDA coming in at £9.0m (vs consensus £8.5m) on sales up 17% LFL to £44m.

Key top & bottom line growth drivers. Start
Q1’23 trading & Integration of HL Healthcare acquisition. 04:55 
Supply chain & input cost inflation. 09:00 
Cash generation & debt reduction plans. 11:20
Outlook & future newsflow. 16:25

Disclosure: Vox paid me to interview Venture Life



Unlock the rest of this article with a 14 day trial

Already have an account?
Login here